Latest Pemetrexed Stories
Testing patients with non-small cell lung cancer for both mutations and amplifications of the KRAS gene prior to therapy may help to predict response to treatment with antifolates.
The Mesothelioma Applied Research Foundation announced its decision to fund five mesothelioma research projects amounting to a total of $500,000 and bringing the Foundation’s overall investment
Jack Clapper is an expert asbestos and mesothelioma attorney and founder of one of the first mesothelioma law firms in California, Clapper Patti Schweizer & Mason (CPSM), which specializes
Last month, the Mesothelioma Applied Research Foundation started a new educational program for mesothelioma patients, their families, and other interested parties.
Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs.
- A poem in which the author retracts something said in an earlier poem.